Formulation Development Applications & Studies
-
Analysis Of Drug-Excipient Incompatibility In Discovery And Formulation Development
3/7/2024
We analyze drug-excipient incompatibility using a microcalorimeter system equipped with a multi-sample cell capable of simultaneously measuring highly sensitive heat flow data from up to three samples.
-
Improving An Abandoned Cancer Medication Using Innovative ASD Technology
3/1/2024
Review the case study and learn how KinetiSol Solid Dispersion lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.
-
Optimized And Scalable LNP Composition For RNA Vaccine Delivery
12/20/2023
Explore results from a study screening novel LNP formulations for physicochemical attributes, in vitro potency, and in vivo immunogenicity in both SARS-CoV-2 and influenza vaccine applications.
-
Production And Purification Of AAV At The 50 L Scale
12/4/2023
Explore data demonstrating the performance of a scalable system for AAV manufacturing that enables gene therapy researchers to utilize a single system throughout the entire development process.
-
Meeting An Aggressive Go-To-Clinic Timeline
9/27/2023
Finding an outsourcing partner capable of giving your company proper attention and meeting project milestones on schedule is crucial to ensuring patients in need receive treatment in a timely manner.
-
Accurate HC-LC Pairing And A Close-To-Nature Solution For bsAbs
9/11/2023
Examine how a proprietary technology ensures high levels of accurate HC-LC pairing without detriment to critical quality attributes such as titer, binding affinity, stability, and immunogenicity.
-
Structural Characterization Of The Cationic LNP Component
8/31/2023
Gain a deeper understanding of how EAD is used when characterizing ALC-0315 and its impurities, as well as identify the nature and site of chemical alterations in ALC-0315 resulting from forced degradation.
-
LCMS/MS Methodology For Mapping Disulfide Linkages In Etanercept
8/28/2023
Learn about the details surrounding the comprehensive mapping of disulfide linkages in etanercept using the EAD approach on an analytical characterization system.
-
Characterize Deglycosylated NISTmAb Using icIEF-UV/MS
8/28/2023
Examine a comprehensive analysis of deglycosylated NISTmAb (dgNISTmAb) using a novel integrated icIEF-UV/MS workflow.
-
Direct And Rapid Multi-Attribute Monitoring Of Multiple Intact mAbs
8/28/2023
What are the results of an innovative system for direct chip-based integration of icIEF with mass spectrometry (MS) being utilized to characterize mAbs spanning a wide pl range?